Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson's disease.
about
Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's diseaseNeurosteroids: endogenous regulators of the GABA(A) receptorSimultaneous quantification of GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in human and rat serum.Neurosteroids and GABAergic signaling in health and diseaseFrontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.Allopregnanolone and neurogenesis in the nigrostriatal tract.Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.Male/Female differences in neuroprotection and neuromodulation of brain dopamineNeurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research.The Brain Metabolome of Male Rats across the Lifespan.Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.Oestrogens and Progestagens: Synthesis and Action in the Brain.3β-hydroxysteroid dehydrogenase in the brain ependymocytes.Brain on steroids resists neurodegeneration.Transient parkinsonism: induced by progesterone or pregnancy?
P2860
Q27334826-2197D21A-A240-4CCE-9220-C6B63DDB399EQ28256904-4C86092A-7BC3-4952-94AC-75F4E7A46050Q33703907-8BCF1049-9859-4AEF-A6F0-F250C0F0AC97Q33792908-1868EB5A-76A3-4D63-84B7-F43225D57A6AQ33972726-F789946E-54E2-4741-8495-D3C063BA17FFQ34033021-77B73D9F-681A-4D6B-96CF-114DE9280CC1Q35947523-E1F78F15-3673-4ACA-8A9E-64A23B386520Q35971342-CE2E3D2D-B047-4026-B763-1E4B9262725EQ35972056-72817565-163D-4228-9FE9-C83178089F4EQ36626032-FA5758A1-195D-4D65-AD6B-74411D89FB01Q36785265-3412F594-915B-45FD-B8AB-8CD4CE9E1A26Q38271572-8A5F96EF-09D1-464B-9D0E-B7F53CE63A44Q38866162-D3D20DB8-BEDA-447F-BB83-7942F63166E7Q43761188-160677F4-5C33-4112-A77C-9E5D628E26B6Q44960540-7AE29FA7-3EC4-4C4D-947A-A2079E5C45F4Q45076613-B1B0E6F5-6635-410E-8734-7F3B7A5CD8FE
P2860
Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson's disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Decreased plasma and cerebrosp ...... eroids in Parkinson's disease.
@en
Decreased plasma and cerebrosp ...... eroids in Parkinson's disease.
@nl
type
label
Decreased plasma and cerebrosp ...... eroids in Parkinson's disease.
@en
Decreased plasma and cerebrosp ...... eroids in Parkinson's disease.
@nl
prefLabel
Decreased plasma and cerebrosp ...... eroids in Parkinson's disease.
@en
Decreased plasma and cerebrosp ...... eroids in Parkinson's disease.
@nl
P2093
P1476
Decreased plasma and cerebrosp ...... teroids in Parkinson's disease
@en
P2093
Bernardi G
Lucchetti S
Pierantozzi M
Stanzione P
di Michele F
P2888
P304
P356
10.1007/S10072-003-0115-1
P577
2003-10-01T00:00:00Z